Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects

Glioblastoma multiforme (GBM) is the most common lethal primary brain malignancy without reliable therapeutic drugs. IL-13Rα2 is frequently expressed in GBMs as a molecular marker. Resveratrol (Res) effectively inhibits GBM cell growth but has not been applied in vivo because of its low brain bioava...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Xiao-Min, Shi, Xiao-Xiao, Xiong, Le, Nie, Jun-Hua, Ye, Hai-Shan, Du, Jin-Zi, Liu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508707/
https://www.ncbi.nlm.nih.gov/pubmed/34638961
http://dx.doi.org/10.3390/ijms221910622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508707/
https://www.ncbi.nlm.nih.gov/pubmed/34638961
http://dx.doi.org/10.3390/ijms221910622

Ejemplares similares